Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Paclitaxel × Breast × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 513 Triple Negative Breast Neoplasms 108 Neoplasm Metastasis 41 Breast Neoplasms, Male 26 Neoplasms 24 Inflammatory Breast Neoplasms 19 Ovarian Neoplasms 18 Carcinoma, Non-Small-Cell Lung 17 Stomach Neoplasms 14 Carcinoma, Ovarian Epithelial 10 Pancreatic Neoplasms 9 Carcinoma, Ductal, Breast 9 Colorectal Neoplasms 8 HER2-positive Breast Cancer 7 Prostatic Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Endometrial Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Melanoma 5 Lung Neoplasms 5 Esophageal Neoplasms 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Anatomic Stage I Breast Cancer AJCC v8 4 Sarcoma 3 Recurrence 3 Peripheral Nervous System Diseases 3 Pathologic Complete Response 3 Lymphoma, Non-Hodgkin 3

Interventions

Patient Reported Outcome Measures 1 Paclitaxel 1 Laser Therapy 1 Electrosurgery 1 Drug Therapy 1 Doxorubicin 1 Cyclophosphamide 1 Carboplatin 1 AC protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05889390 2024-12-03

NeoHTerMa

Semmelweis University

Phase 2/3 Active not recruiting

Hyperthermia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡